0001103021-19-000037.txt : 20191119 0001103021-19-000037.hdr.sgml : 20191119 20191119163652 ACCESSION NUMBER: 0001103021-19-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191118 FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plesha Scott M. CENTRAL INDEX KEY: 0001726687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 191231748 MAIL ADDRESS: STREET 1: 1410 SMYTHE ST CITY: DANIEL ISLAND STATE: SC ZIP: 29492 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_157419939601689.xml FORM 4 X0306 4 2019-11-18 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001726687 Plesha Scott M. C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 0 1 0 0 See Remarks Common Stock 2019-11-18 4 S 0 25000 6.06 D 257336 D The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan. On November 18, 2019, the Reporting Person sold an aggregate of 25,000 shares of the Issuer's Common Stock at a weighted average price of $6.06 per share. The highest sale price for the Common Stock was $6.16 per share and the lowest sale price was $6.01 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. /s/ Scott Plesha 2019-11-19